Dr Rajaventhan Srirajaskanthan
Consultant in Gastroenterology and Neuroendocrine Tumours
- Year Qualified
- 2001
- Qualifications
- BSc (Hons), MBBS, MD, FRCP
- Specialty
- Gastroenterology and General Internal Medicine
Special Interests
- Bowel cancer screening
- Neuroendocrine tumours
Biography
Dr Srirajaskanthan is a Consultant in Gastroenterology and Neuroendocrine tumours. He is clinical lead of Gastroenterology and Head of the King’s Health Partners European NET Centre of Excellence. He is deputy director for the bowel cancer screening centre.
Related services
Research
-
Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK (2014) ‘Review article: investigation and management of gastric neuroendocrine tumours‘, Alimentary pharmacology & therapeutics, ():
-
Srirajaskanthan R, Ahmed A, Prachialias A, Srinivasan P, Heaton N, Jervis N, Quaglia A, Vivian G, Ramage JK (2013) ‘ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours‘, ISRN oncology, 2013,():420795
-
Srirajaskanthan R, Shanmugabavan D, Ramage JK (2010) ‘Carcinoid syndrome‘, BMJ (Clinical research ed.), 341,():c3941
-
Srirajaskanthan R, Kayani I, Quigley AM, Soh J, Caplin ME, Bomanji J (2010) ‘The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy‘, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 51,(6):875-82
-
Srirajaskanthan R, Conn R, Bulwer C, Irving P (2010) ‘The Glasgow Blatchford scoring system enables accurate risk stratification of patients with upper gastrointestinal haemorrhage‘, International journal of clinical practice, 64,(7):868-74